Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F1G94
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,524
Award facts
- Contract value 100% obligated
- $37,523.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,523.56 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 13, 2025. This is a firm fixed-price contract with no set-aside designation, executed competitively. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order, this award draws from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle extending through December 2026 that enables the company to supply medications and medical supplies globally to military healthcare programs.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. Repatha (evolocumab) is a PCSK9 inhibitor used for cholesterol management in patients with cardiovascular disease. This delivery order reflects the company's established role as a primary vendor within DLA's pharmaceutical supply chain, leveraging its capability to fulfill federal medical supply requirements across diverse therapeutic domains including specialty medications, brand-name drugs, and auto-injector delivery systems.
Quick answers
Who was awarded contract SPE2DR26F1G94?
SPE2DR26F1G94 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F1G94 worth?
The government has obligated $37,524 on SPE2DR26F1G94.
Is contract SPE2DR26F1G94 an order under another contract?
Yes. SPE2DR26F1G94 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1G94 competed?
The extent of competition for SPE2DR26F1G94 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award